- CEO
- Vinati Saraf Mutreja
- Full Time Employees
- 2,109
- Sector
- Process industries
- Industry
- Chemicals: specialty
- Address
- Parinee Crescenzo, 1102 Mumbai MA India 400051
- IPO Date
- Jun 15, 1989
- Business
- Vinati Organics Limited Vinati Organics Limited manufactures specialty organic chemicals and intermediates, including Isobutylbenzene (IBB), the world's largest produced raw material for Ibuprofen; 2-Acrylamido-2-Methylpropane Sulfonic Acid (ATBS) and its sodium salt (Na-ATBS); Normal Butylbenzene (NBB); n-Tertiary Butyl Acrylamide (TBA); Butyl Phenols; High Purity Methyl Tertiary Butyl Ether (HP-MTBE); and other niche products such as TB Amine, TOA, PTBT, PTBBA, PTBMB, MEHQ, Guaiacol, Iso Amylenes, and Anisole. The company serves pharmaceuticals, personal care and cosmetics, food and beverage, polymers and resins, agrochemicals, perfumery, construction, and flavors and fragrances industries, with operations spanning over 35 countries including the US, Europe, Asia, and the Middle East. Incorporated in 1989 and headquartered in Mumbai, India, with manufacturing facilities in Mahad and Lote Parshuram in Maharashtra, Vinati Organics Limited maintains state-of-the-art production capabilities focused on high-purity, eco-friendly chemicals through in-house research and development. In recent developments, the company invested ₹38.45 crore in November 2025 into its wholly-owned subsidiary Veeral Organics Private Limited via a rights issue, subscribing to additional equity shares to support organic fine specialty chemicals manufacturing; it previously invested ₹55.77 crore in the subsidiary; expanded ATBS capacity from 40,000 MT to 60,000 MT with plans for further expansions in MEHQ, Guaiacol, Iso Amylenes, and Anisole; and established a US subsidiary in early 2025 for raw material procurement, processing, and distribution of specialty chemicals.